Page last updated: 2024-08-17

medroxyprogesterone acetate and Carcinoma, Anaplastic

medroxyprogesterone acetate has been researched along with Carcinoma, Anaplastic in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (30.19)	18.7374
1990's	16 (30.19)	18.2507
2000's	12 (22.64)	29.6817
2010's	8 (15.09)	24.3611
2020's	1 (1.89)	2.80

Authors

Authors	Studies
Bloy, N; Buqué, A; Galluzzi, L; Humeau, J; Kroemer, G; Perez-Lanzón, M; Petroni, G; Sato, A; Yamazaki, T	1
Beck, AP; Erdelyi, I; Zeiss, CJ	1
Aldossary, M; Arendas, K; Cipolla, A; Leader, A; Leyland, NA	1
Harrigan, RC; Mori, H; Niwa, K; Onogi, K; Tamaya, T; Wu, Y	1
Giulianelli, S; Gutkind, JS; Herschkowitz, JI; Lamb, CA; Lanari, C; Molinolo, A; Patel, V; Perou, CM	1
Hu, Q; Ji, L; Liao, QP; Wang, YL; Xie, Y; Yu, L; Zhang, Y	1
Kahan, BC; Morris, TP	1
Ai, Z; Teng, Y; Tong, J; Wang, J; Xu, Y	1
Chen, R; Hu, Q; Ji, L; Liao, QP; Wang, YL; Xie, Y; Yu, L; Zhang, Y	1
Giulianelli, S; Gutkind, JS; Helguero, L; Lamb, C; Lanari, C; Martins, R; Molinolo, AA; Soldati, R; Vanzulli, SI; Vaqué, JP; Wargon, V; Zeitlin, E	1
Helguero, LA; Lamb, C; Lanari, C; Molinolo, AA	1
Fujita, K; Kase, H; Kurabayashi, T; Sugaya, S; Suzuki, M; Tanaka, K	1
Lian, Z; Mori, H; Niwa, K; Onogi, K; Tagami, K; Tamaya, T	1
Bamberger, AM; Briese, J; Erdmann, I; Götze, J; Nollau, P; Schulte, HM; Wagener, C	1
Choshi, T; Fujimori, S; Hibino, S; Ichihara, Y; Murata, N; Nemoto, H; Nobuhiro, J; Oikawa, T; Sato, Y; Suzuki, H; Tsuboi, H; Uchida, M; Yamada, M; Yamaji, T	1
Archer, DF; den Hollander, W; Ferenczy, A; Gallagher, JC; Helmond, FA; Hendrix, S; Rymer, J; Skouby, S; Stathopoulos, V	1
Fukunaga, M; Hatae, M; Hiura, M; Iwasaka, T; Kamura, T; Kodama, S; Konishi, I; Nakanishi, T; Saito, T; Saji, F; Sakamoto, A; Sasaki, H; Terakawa, N; Tsuda, H; Ushijima, K; Yaegashi, N; Yahata, H; Yasugi, T; Yoshikawa, H	1
Grönroos, M; Kauppila, A; Nieminen, U	1
Bücke, W; Neumann, HA; Runge, HM	1
Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N	1
Burger, CW; Greggi, S; Kenemans, P; van der Vange, N; Vermorken, JB	1
Espie, M	1
Alkhalaf, M; Murphy, LC; Murphy, LJ	1
Bélanger, A; Labrie, F; Lepage, M; Li, S; Mérand, Y	1
Beecham, JB; Bundy, BN; Hatch, KD; Malfetano, J	1
Joosten, JW; Kloosterboer, HJ; Schoonen, WG	1
Hackenberg, R; Schulz, KD	1
Berek, JS; Kim, YB; Martinez-Maza, O; Satyaswaroop, PG	1
Baker, P; Blackledge, GR; Clinton, OP; Dunn, J; Earl, H; Latief, TN; Murphy, A; Priestman, TJ	1
Aravantinos, G; Bafaloukos, D; Bakoyiannis, C; Katsifis, G; Kosmidis, P; Samonis, G; Skarlos, D	1
Adelson, MD; Alvarez, RD; Brady, MF; Given, FT; Homesley, HD; Manetta, A; Soper, JT; Thigpen, JT	1
Abe, M; Ogawa, M; Yamashita, J	1
Arcuri, F; Carducci, A; Cintorino, M; Paulesu, L; Ricci, C; Runci, Y; Sestini, S	1
Satyaswaroop, PG; Tabibzadeh, S	1
Lippert, C; Mueck, AO; Seeger, H; Wallwiener, D	1
Campobasso, C; De Paoli, D; Giulini, D; Levato, F; Pansini, F; Serra, MM	1
Hortobagyi, GN; Hug, V; Jones, L; Kau, S	1
Atkinson, EN; Freedman, RS; Fritsche, HA; Fromm, GL; Scott, W	1
Rao, BR; Slotman, BJ	1
Sevelda, P	1
Banno, T; Kimura, T; Kutsuna, T; Matsumoto, S; Mizuno, Y; Shinohara, M; Tann, M; Yoshizaki, S	1
Gimes, G; Hidvégi, J; Szarvas, Z; Zsolnai, B	2
Enomoto, K; Fukutomi, T; Ikeda, T; Ishibiki, K; Isobe, Y; Kikuyama, S; Kubota, T; Nakamura, A; Nishiumi, T; Shimada, A	1
Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G	1
Manni, A	1
Clarke, CL; Mortel, R; Satyaswaroop, PG; Zaino, R	1
de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S	1
Carey, TE; England, BG; Grenman, SE; Grönroos, M; Roberts, JA	1
Flamm, J; Spona, J	1
Bollack, C; Rougeron, G	1
Hamerlynck, JV; Mangioni, C; Maskens, AP; Rotmensz, N; van der Burg, ME; Vermorken, JB; Wils, JA	1
Johansson, JE; Lingårdh, G	1

Reviews

5 review(s) available for medroxyprogesterone acetate and Carcinoma, Anaplastic

Article	Year
Hysteroscopic resection in the management of early-stage endometrial cancer: report of 2 cases and review of the literature. Journal of minimally invasive gynecology, 2015, Volume: 22, Issue:1 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Protocols; Carcinoma; Dilatation and Curettage; Disease Management; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Treatment Outcome	2015
Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 56, Issue:1-6 Spec N Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenediol; Antineoplastic Agents, Hormonal; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoma; Carrier Proteins; Endometrial Neoplasms; Estrogen Antagonists; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Pleural Effusion; Receptors, Androgen; Tumor Cells, Cultured	1996
Endocrine factors in common epithelial ovarian cancer. Endocrine reviews, 1991, Volume: 12, Issue:1 Topics: Carcinoma; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Progesterone; Prognosis; Receptors, Cell Surface; Receptors, Estrogen; Tamoxifen	1991
[Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results]. Wiener klinische Wochenschrift. Supplementum, 1990, Volume: 183 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Resistance; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Tumor Stem Cell Assay	1990
Tamoxifen therapy of metastatic breast cancer. The Journal of laboratory and clinical medicine, 1987, Volume: 109, Issue:3 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen	1987

Trials

10 trial(s) available for medroxyprogesterone acetate and Carcinoma, Anaplastic

Article	Year
Endometrial effects of tibolone. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:3 Topics: Aged; Carcinoma; Cohort Studies; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Pain; Uterine Hemorrhage	2007
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jul-01, Volume: 25, Issue:19 Topics: Adult; Aspirin; Carcinoma; Disease-Free Survival; Endometrial Neoplasms; Endometrium; Female; Fertility; Humans; Hyperplasia; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Outcome; Prospective Studies; Treatment Outcome; Uterine Diseases	2007
A phase II trial of medroxyprogesterone acetate in epithelial ovarian cancers. A Gynecologic Oncology Group study. American journal of clinical oncology, 1993, Volume: 16, Issue:2 Topics: Adult; Aged; Carcinoma; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Survival Analysis	1993
A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 1995, Volume: 7, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Drug Administration Schedule; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Progesterone Congeners; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen; Time Factors	1995
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic cooperative oncology group study. Oncology, 1999, Volume: 56, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Drug Synergism; Endometrial Neoplasms; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome	1999
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:6 Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma; Disease-Free Survival; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Receptors, Progesterone; Recurrence; Survival Rate; Treatment Outcome	1999
[Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results]. Wiener klinische Wochenschrift. Supplementum, 1990, Volume: 183 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Resistance; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Tumor Stem Cell Assay	1990
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological The Journal of urology, 1986, Volume: 136, Issue:3 Topics: Aged; Bone Neoplasms; Carcinoma; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms; Random Allocation	1986
Tamoxifen therapy of metastatic breast cancer. The Journal of laboratory and clinical medicine, 1987, Volume: 109, Issue:3 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen	1987
Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762. Progress in clinical and biological research, 1988, Volume: 260 Topics: Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Random Allocation	1988

Other Studies

40 other study(ies) available for medroxyprogesterone acetate and Carcinoma, Anaplastic

Article	Year
MPA/DMBA-driven mammary carcinomas. Methods in cell biology, 2021, Volume: 163 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Carcinoma; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL	2021
Endometrial decidualization and deciduosis in aged rhesus macaques (Macaca mulatta). Comparative medicine, 2014, Volume: 64, Issue:2 Topics: Actins; Animals; Carcinoma; Cell Differentiation; Cell Proliferation; Choristoma; Collagen Type IV; Colonic Neoplasms; Decidua; Female; Immunohistochemistry; Macaca mulatta; Medroxyprogesterone Acetate; Monkey Diseases; Neprilysin; Pregnancy; Vimentin	2014
Clinical implication of medroxyprogesterone acetate against advanced ovarian carcinoma: a pilot study. European journal of gynaecological oncology, 2008, Volume: 29, Issue:3 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Neoplasm Staging; Ovarian Neoplasms; Pilot Projects; Prognosis	2008
MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements. Breast cancer research and treatment, 2011, Volume: 129, Issue:1 Topics: Animals; Antineoplastic Agents, Hormonal; Carcinoma; Cluster Analysis; Epithelial Cells; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Reproducibility of Results; Stromal Cells	2011
Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. The Journal of steroid biochemistry and molecular biology, 2011, Volume: 126, Issue:3-5 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Medroxyprogesterone Acetate; Metformin; Models, Biological; Receptors, Progesterone; Signal Transduction; TOR Serine-Threonine Kinases	2011
Improper analysis of trials randomised using stratified blocks or minimisation. Statistics in medicine, 2012, Feb-20, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Back Injuries; Bias; Breast Neoplasms; Carcinoma; Computer Simulation; Data Interpretation, Statistical; Deoxyribonucleases; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Interferon-alpha; Kidney Neoplasms; Liver Cirrhosis, Biliary; Male; Medroxyprogesterone Acetate; Penicillamine; Pleural Effusion; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Tissue Plasminogen Activator; Treatment Outcome	2012
Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model. The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:12 Topics: Animals; Antineoplastic Agents, Hormonal; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Therapy, Combination; Endometrial Neoplasms; ErbB Receptors; Female; Gefitinib; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Phosphorylation; Quinazolines; Receptors, Progesterone; Signal Transduction; Xenograft Model Antitumor Assays	2012
5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:6 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Apoptosis; Azacitidine; Carcinoma; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Decitabine; Drug Synergism; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Receptors, Progesterone	2012
[The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins]. Medicina, 2012, Volume: 72, Issue:4 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Cell Proliferation; Chromatin Immunoprecipitation; Cyclin D1; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Genes, myc; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Murinae; Progestins; Receptors, Progesterone; Transcription, Genetic	2012
Evidence for two progesterone receptor binding sites in murine mammary carcinomas. The Journal of steroid biochemistry and molecular biology, 2003, Volume: 84, Issue:1 Topics: Animals; Binding Sites; Carcinoma; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Female; Fibroblasts; Kinetics; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Progesterone Congeners; Progestins; Protein Binding; Receptors, Progesterone; Time Factors; Uterus	2003
Endometrial abnormalities in infertile women. The Journal of reproductive medicine, 2003, Volume: 48, Issue:6 Topics: Adult; Carcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Infertility, Female; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Rate; Progesterone Congeners; Prognosis; Reproductive Techniques, Assisted; Retrospective Studies	2003
Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG : an international journal of obstetrics and gynaecology, 2005, Volume: 112, Issue:3 Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Carcinoma; Carcinoma, Adenosquamous; Cohort Studies; Combined Modality Therapy; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Follow-Up Studies; Humans; Infertility, Female; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Treatment Outcome	2005
Stimulation of CEACAM1 expression by 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophore A23187 in endometrial carcinoma cells. Carcinogenesis, 2006, Volume: 27, Issue:3 Topics: Anti-Bacterial Agents; Antigens, CD; Calcimycin; Carcinoma; Cell Adhesion Molecules; Endometrial Neoplasms; Estradiol; Female; Hormone Antagonists; Humans; Interferon-gamma; Medroxyprogesterone Acetate; Mifepristone; Phorbol Esters; Protein Kinase C; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2006
Synthesis and anti-tumor activity of a fluorinated analog of medroxyprogesterone acetate (MPA), 9alpha-fluoromedroxyprogesterone acetate (FMPA). Chemical & pharmaceutical bulletin, 2006, Volume: 54, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma; Drug Screening Assays, Antitumor; Female; Fluorine; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Molecular Conformation; Rats; Rats, Sprague-Dawley; Stereoisomerism	2006
Clinical outcome in endometrial cancer. Obstetrics and gynecology, 1982, Volume: 60, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms	1982
[Significance of the colony formation test in ovarian carcinoma]. Onkologie, 1984, Volume: 7 Suppl 2 Topics: Agar; Antineoplastic Agents; Carcinoma; Cells, Cultured; Colony-Forming Units Assay; Drug Resistance; Estradiol; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Methylcellulose; Ovarian Neoplasms; Progesterone; Prognosis; Tamoxifen; Tumor Stem Cell Assay	1984
Inhibition of steroid sulfatase activity by danazol. Acta obstetricia et gynecologica Scandinavica. Supplement, 1984, Volume: 123 Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen	1984
Experience with hormonal therapy in advanced epithelial ovarian cancer. Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Carcinoma; Estrogen Antagonists; Female; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteolytic Agents; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Ovarian Neoplasms; Progesterone Congeners; Remission Induction; Survival Rate; Tamoxifen; Triptorelin Pamoate	1995
Megestrol acetate in advanced breast carcinoma. Oncology, 1994, Volume: 51 Suppl 1 Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome	1994
Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells. Molecular endocrinology (Baltimore, Md.), 1993, Volume: 7, Issue:12 Topics: Carcinoma; Cell Division; Depression, Chemical; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Neoplasm Proteins; Proto-Oncogene Proteins c-jun; Receptors, Glucocorticoid; Receptors, Progesterone; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured	1993
Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate. Breast cancer research and treatment, 1992, Volume: 24, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma; Delayed-Action Preparations; Female; Follicle Stimulating Hormone; Injections, Subcutaneous; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Microspheres; Rats; Rats, Sprague-Dawley	1992
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured	1995
Vascular endothelial growth factor expression is not regulated by estradiol or medroxyprogesterone acetate in endometrial carcinoma. Gynecologic oncology, 1996, Volume: 61, Issue:1 Topics: Actins; Animals; Carcinoma; Endometrial Neoplasms; Endothelial Growth Factors; Estradiol; Female; Humans; Lymphokines; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1996
Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation. Cancer, 2000, May-01, Volume: 88, Issue:9 Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Carcinoma; Cell Adhesion; Cell Count; Cell Nucleus; DNA Fragmentation; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Growth Inhibitors; Humans; Immunoblotting; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	2000
Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells. The Journal of steroid biochemistry and molecular biology, 2000, Volume: 72, Issue:5 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Breast Neoplasms; Carcinoma; Corticosterone; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Gene Expression Regulation, Enzymologic; Humans; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Mifepristone; NAD; Progesterone Congeners; Progestins; RNA, Messenger; Tumor Cells, Cultured	2000
Progestin regulation of human endometrial function. Human reproduction (Oxford, England), 2000, Volume: 15 Suppl 1 Topics: Animals; Carcinoma; Crystallins; Embryo Implantation; Endometrial Neoplasms; Endometrium; Epithelial Cells; Female; Humans; Medroxyprogesterone Acetate; Mice; Mice, Nude; Progesterone; Progesterone Congeners; Progestins; Transplantation, Heterologous	2000
The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment. European journal of gynaecological oncology, 2001, Volume: 22, Issue:5 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Estradiol; Estrogen Replacement Therapy; Female; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Progestins; Tumor Cells, Cultured	2001
Combined use of progesterone challenge test and endometrium thickness evaluated by transvaginal ultrasonography in the preventive management of postmenopausal women. Gynecologic and obstetric investigation, 1992, Volume: 34, Issue:4 Topics: Carcinoma; Endometrial Neoplasms; Endometrium; Female; Humans; Mass Screening; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone; Risk Factors; Ultrasonography	1992
Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone. British journal of cancer, 1991, Volume: 63, Issue:3 Topics: Adrenal Glands; Adrenal Insufficiency; Adult; Aged; Breast Neoplasms; Carcinoma; Drug Administration Schedule; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1991
Sequentially administered ethinyl estradiol and medroxyprogesterone acetate in the treatment of refractory epithelial ovarian carcinoma in patients with positive estrogen receptors. Cancer, 1991, Nov-01, Volume: 68, Issue:9 Topics: Administration, Oral; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Prospective Studies; Receptors, Estrogen; Remission Induction	1991
[Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Tamoxifen; Tegafur	1989
[Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma]. Morphologiai es igazsagugyi orvosi szemle, 1985, Volume: 25, Issue:4 Topics: Aged; Carcinoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrium; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron, Scanning; Preoperative Care; Uterine Neoplasms	1985
Experimental combined hormone therapy on human breast carcinomas serially transplanted into nude mice. Japanese journal of cancer research : Gann, 1986, Volume: 77, Issue:1 Topics: Adult; Aminoglutethimide; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organ Size; Tamoxifen; Transplantation, Heterologous; Uterus	1986
Nude mouse system in the study of tumor biology, treatment strategies and progesterone receptor physiology in human endometrial carcinoma. Journal of steroid biochemistry, 1987, Volume: 27, Issue:1-3 Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Differentiation; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Transplantation, Heterologous; Uterine Neoplasms	1987
Continuous, high-dose progestogen treatment of endometrial cancer. Gynecologic and obstetric investigation, 1987, Volume: 24, Issue:4 Topics: Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Microscopy, Electron, Scanning; Uterine Neoplasms	1987
In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate. Gynecologic oncology, 1988, Volume: 30, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line; Depression, Chemical; Drug Evaluation; Drug Evaluation, Preclinical; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Postoperative Care; Receptors, Steroid; Tamoxifen; Tumor Cells, Cultured; Uterine Neoplasms	1988
The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients. International urology and nephrology, 1988, Volume: 20, Issue:2 Topics: Aged; Aged, 80 and over; Carcinoma; Dose-Response Relationship, Drug; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone	1988
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study. American journal of clinical oncology, 1988, Volume: 11 Suppl 2 Topics: Androgen Antagonists; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms	1988
Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study. Gynecologic oncology, 1985, Volume: 22, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Evaluation; Drug Resistance; Endometriosis; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms	1985
High-dose medroxyprogesterone in the treatment of advanced therapy-resistant prostatic carcinoma. European urology, 1985, Volume: 11, Issue:1 Topics: Aged; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms	1985